mrna-quality-control.com
Open in
urlscan Pro
5.134.13.35
Public Scan
Submitted URL: https://www.mrna-quality-control.com/
Effective URL: https://mrna-quality-control.com/
Submission: On January 12 via automatic, source certstream-suspicious — Scanned from GB
Effective URL: https://mrna-quality-control.com/
Submission: On January 12 via automatic, source certstream-suspicious — Scanned from GB
Form analysis 1 forms found in the DOM
GET https://mrna-quality-control.com/
<form role="search" method="get" id="searchform" class="searchform" action="https://mrna-quality-control.com/">
<div>
<label class="screen-reader-text" for="s"> Search</label>
<input type="text" value="" name="s" id="s" placeholder="">
<input type="submit" id="searchsubmit" value="Search">
</div>
</form>Text Content
Skip to content DECEMBER 11-13 BOSTON, MA, USA Menu * Home * About * About Event * Why Choose Us? * Speakers * Pre-Conference Fundamentals Focus Day * Post-Conference Workshop Day * Agenda * Full event guide * Venue * Partnership * Partnership Opportunities * Get involved * Register * Pricing * Contact us 1 2 3 FULL EVENT GUIDE PARTNER REGISTER NOW H1 TITLE PLACEHOLDER Globally it’s estimated 1 in 7 people suffer from migraines. It is one of the most disabling, misunderstood and underfunded diseases that costs the U.S. approximately $22 billion annually in direct and indirect costs to the economy. The inaugural World Migraine Forum is the industry’s first dedicated discussion and networking forum focused on bringing together migraine thought-leaders to share the latest scientific progress and to address the current challenges drug developers are facing. With the recent scientific breakthroughs and excitement surrounding CGRP antibodies and approvals, this is an exciting time for migraine drug development. As the race for the next approval is on, join over 60 of your peers at this intimate discussion led forum to establish new relationships and accelerate your migraine drug development. Download the full event guide here Developed with experts from Teva, Allergan, Eli Lilly and other leading organisations, this industry focused forum allows you to explore novel targets and mechanisms of action, share lesson learned in mitigating the placebo response and the pathophysiology of migraine and what this means for the future of migraine drug development to name a few. Leave WMF with a deeper understanding of the current migraine landscape and where key industry stakeholders are directing their next steps for migraine drug development. Download the full event guide here to view the complete agenda and companies speaking. “I was impressed by many of the speakers and learnt a significant amount, which I was able to bring back to our discovery team.” Stephen Krause, Senior Principal Scientist, Eisai “Excellent networking and learning opportunity for pharma scientists.” Matthew Kennedy, Director, Merck “The quality of talks was high and the discussion very interesting.” Claudio Babiloni, Associate Professor, University of Rome OUR CONTACT DETAILS T: +44 (0)20 3141 8700 E: info@hansonwade.com VENUE DETAILS Park Plaza Waterloo Hercules House 6 Hercules Rd, Lambeth London SE1 7DP ABOUT US Hanson Wade's goal is to accelerate progress within organisations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers. LOCATION SEARCH Search ORGANISED BY Terms & Conditions Privacy Policy © Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216. Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.